Holen Sie sich die Stockscreener-App
23.56
2.52%
0.58
Handel nachbörslich:
23.17
-0.39
-1.66%
Schlusskurs vom Vortag:
$22.98
Offen:
$23
24-Stunden-Volumen:
1.75M
Relative Volume:
1.03
Marktkapitalisierung:
$3.02B
Einnahmen:
$2.89B
Nettoeinkommen (Verlust:
$-33.80M
KGV:
-87.26
EPS:
-0.27
Netto-Cashflow:
$204.10M
1W Leistung:
+5.13%
1M Leistung:
+6.90%
6M Leistung:
-8.65%
1J Leistung:
-21.47%
1-Tages-Spanne:
$23.00
$23.82
1-Wochen-Bereich:
$22.25
$23.92
52-Wochen-Spanne:
$18.87
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Vergleichen Sie SGRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
23.56 | 2.92B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
390.46 | 91.33B | 72.70B | 5.97B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
171.87 | 14.72B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.84 | 14.15B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
119.13 | 11.83B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
178.51 | 10.92B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Surgery Partners director Maryland sells $455k in shares - Investing.com
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
SGRY Q2 Deep Dive: Orthopedics and De Novo Expansion Drive Steady Growth - Yahoo Finance
Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2025 Earnings Call Transcript - MSN
Can Surgery Partners Inc. hit a new high this monthNeural Model for Stock Price Movement - Newser
Published on: 2025-08-08 23:19:54 - Newser
Long term hold vs stop loss in Surgery Partners Inc.High Confidence Strategy with Trend Alignment - Newser
Candlestick signals on Surgery Partners Inc. stock todaySmart Trade Forecast Based on Neural Logic - Newser
Insider Sales and Shareholder Confidence in Surgery Partners (SGRY): A Closer Look at CFO David Doherty's $1.11 Million Transaction - AInvest
Surgery Partners Insider Sold Shares Worth $1,110,814, According to a Recent SEC Filing - MarketScreener
Zurcher Kantonalbank Zurich Cantonalbank Decreases Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
Surgery Partners Reports Revenue Growth Amid Net Loss - TipRanks
Capitalizing on Undervalued Sectors: Why Brown & Brown and Surgery Partners Are Strategic Buys in a Shifting Market - AInvest
Surgery Partners Appoints New Chairman After Resignation - The Globe and Mail
Surgery Partners, Inc. shares rise 1.76% intraday after UNC Health Rex Hospital and Brasseler Surgical collaboration. - AInvest
Surgery Partners outlines $200M acquisition target and signals leverage reduction focus amid robust organic growth - MSN
Surgery Partners stock rating reiterated by Benchmark on solid positioning - Investing.com South Africa
Surgery Partners: Q2 Earnings Snapshot - Huron Daily Tribune
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates - MSN
Surgery Partners 2025 Q2 Earnings Strong Performance as Net Income Surges 58.1% - AInvest
Surgery Partners Inc (SGRY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Surgery Partners (SGRY) Q2 Revenue Up 8% - The Motley Fool
Surgery Partners Inc. Earnings Call: Growth Amid Challenges - TipRanks
Surgery Partners, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Surgery Partners beats Q2 2025 earnings expectations By Investing.com - Investing.com Canada
Earnings call transcript: Surgery Partners beats Q2 2025 earnings expectations - Investing.com
Surgery Partners' Q2 2025: Unraveling Contradictions in M&A Strategy, Financial Goals, and Legislation Impact - AInvest
Surgery Partners Q2 Financial Results: Surpassing ExpectationsNews and Statistics - IndexBox
Surgery Partners beats Q2 expectations, reaffirms 2025 guidance - MSN
Surgery Partners (NASDAQ:SGRY) Surprises With Q2 Sales - Yahoo Finance
Surgery Partners Q2 Adjusted Earnings Fall, Revenue Rises; Reaffirms 2025 Revenue Guidance - MarketScreener
Surgery Partners Inc Reports Q2 2025 Revenue of $826.2M, Exceedi - GuruFocus
Surgery Partners reports Q2 adjusted EPS 17c, consensus 14c - TipRanks
Surgery Partners Inc earnings beat by $0.01, revenue topped estimates - Investing.com South Africa
Surgery Partners beats Q2 expectations, reaffirms 2025 guidance By Investing.com - Investing.com Canada
Surgery Partners beats Q2 revenue estimates, reaffirms guidance - MarketScreener
Surgery Partners, Inc. Reports Second Quarter 2025 Financial Results with 8.4% Revenue Growth and Reaffirms Full Year Guidance - Quiver Quantitative
Surgery Partners, Inc. Announces Second Quarter 2025 Results - TradingView
Earnings Flash (SGRY) Surgery Partners, Inc. Posts Q2 Adjusted EPS $0.17 per Share, vs. FactSet Est of $0.18 - MarketScreener
How to forecast Surgery Partners Inc. trends using time seriesStock Portfolio Risk and Return Analysis - Newser
Surgery Partners Inc (SGRY) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Does Surgery Partners Inc. fit your quant trading modelCapital Growth Plan for New Investors - Newser
Should I hold or sell Surgery Partners Inc. stock in 2025Unlock superior stock analysis tools - Jammu Links News
What makes Surgery Partners Inc. stock price move sharplyAchieve consistent high returns with low risk - Jammu Links News
Surgery Partners (SGRY) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Surgery Partners Inc. Stock Analysis and ForecastGet exclusive access to professional stock picks - Jammu Links News
What analysts say about Surgery Partners Inc. stockDynamic profit opportunities - Jammu Links News
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surgery Partners Inc-Aktie (SGRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Doherty David T | Chief Financial Officer |
Aug 08 '25 |
Sale |
23.39 |
47,491 |
1,110,814 |
103,377 |
0.03%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):